TLPH Q1 2022 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q1 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$41,000

Operating Income

-$5M

Net Income

-$9M

EPS (Diluted)

$-1.19

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$783,000

Balance Sheet

Total Assets

$72M

Total Liabilities

$110M

Stockholders' Equity

-$38M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$511,000	-100.0%
Gross Profit	-$41,000	-$529,000	+92.2%
Operating Income	-$5M	-$9M	+46.0%
Net Income	-$9M	-$9M	+3.1%